For example, the Alliance for Biosecurity and MDB Communications produced a joint industry report titled “Medical Countermeasures: A Roundtable Discussion” to provide valuable information about the field from key opinion leaders, analysts, and industry executives. In total, a panel of 16 experts participated, sharing their reflections on important advancements, lessons learned, core challenges and recommendations for the future of the medical countermeasures enterprise.
To access/view a PDF version of the full Medical Countermeasure Roundtable report, please click here.
In June 2011, we partnered with the Cancer Research Institute (CRI) and released a joint report titled “Cancer Immunotherapy: A Roundtable Discussion.” The report provided valuable information about the field from key opinion leaders, analysts, and industry executives. In total, a panel of 17 experts participated, exchanging data, knowledge, and experience through discussion and debate about the current status and the future outlook for cancer immunotherapy. The roundtable started with general questions and topics about cancer immunotherapy posed by the organizers, followed by a comprehensive discussion among the various participants. The resulting publication also provided detailed descriptions of approximately 40 unique active cancer immunotherapies that were being tested in nearly 60 clinical trials, including almost a dozen that were in late-stage development.
To access/view a PDF version of the full Cancer Immunotherapy Roundtable report, please click here.